The burden of cervical cancer in China: synthesis of the evidence.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMID 21387308)

Published in Int J Cancer on June 10, 2011

Authors

Ju-Fang Shi1, Karen Canfell, Jie-Bin Lew, You-Lin Qiao

Author Affiliations

1: Cancer Epidemiology Research Unit, Cancer Council NSW, New South Wales, Australia.

Articles citing this

Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer (2012) 1.32

Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer (2011) 1.16

Lower cost strategies for triage of human papillomavirus DNA-positive women. Int J Cancer (2013) 1.02

Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: a study of 10,012 cases from a nationwide working group. Oncologist (2013) 1.01

Clinical application of DNA ploidy to cervical cancer screening: A review. World J Clin Oncol (2014) 0.93

Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial. Int J Cancer (2014) 0.92

Human papillomavirus genital infections among men, China, 2007-2009. Emerg Infect Dis (2013) 0.91

Acceptability and correlates of primary and secondary prevention of cervical cancer among medical students in southwest China: implications for cancer education. PLoS One (2014) 0.89

HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study. Asian Pac J Cancer Prev (2012) 0.87

MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis. Int J Med Sci (2014) 0.84

Comparison of HPV genotyping and methylated ZNF582 as triage for women with equivocal liquid-based cytology results. Clin Epigenetics (2015) 0.83

Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing study. BMC Health Serv Res (2012) 0.81

Cancer burden in China and the role of the cancer registries. Ann Transl Med (2014) 0.80

The impact of HPV vaccination delays in China: lessons from HBV control programs. Vaccine (2013) 0.80

Conization Using an Electrosurgical Knife for Cervical Intraepithelial Neoplasia and Microinvasive Carcinoma. PLoS One (2015) 0.78

Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway. Oncotarget (2016) 0.78

Cyclin D1b overexpression inhibits cell proliferation and induces cell apoptosis in cervical cancer cells in vitro and in vivo. Int J Clin Exp Pathol (2014) 0.77

Low folate levels are associated with methylation-mediated transcriptional repression of miR-203 and miR-375 during cervical carcinogenesis. Oncol Lett (2016) 0.76

Inhibition of antiviral drug cidofovir on proliferation of human papillomavirus-infected cervical cancer cells. Exp Ther Med (2016) 0.75

High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population. J Gynecol Oncol (2017) 0.75

1-(2-Hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione Induces G1 Cell Cycle Arrest and Autophagy in HeLa Cervical Cancer Cells. Int J Mol Sci (2016) 0.75

Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China. BMC Cancer (2016) 0.75

Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years. Hum Vaccin Immunother (2014) 0.75

Association between folate status and cervical intraepithelial neoplasia. Eur J Clin Nutr (2016) 0.75

Synergistic effects of a novel lipid-soluble extract from Pinellia pedatisecta Schott and cisplatin on human cervical carcinoma cell lines through the regulation of DNA damage response signaling pathway. Oncol Lett (2017) 0.75

Health Disparity and Cancer Health Disparity in China. Asia Pac J Oncol Nurs (2017) 0.75

Prevalence of genital human papillomavirus among rural and urban populations in southern Yunnan province, China. Braz J Med Biol Res (2016) 0.75

Synergistic cytotoxic effects of a combined treatment of a Pinellia pedatisecta lipid-soluble extract and cisplatin on human cervical carcinoma in vivo. Oncol Lett (2017) 0.75

Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China. PLoS One (2017) 0.75

Articles by these authors

Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer (2005) 4.69

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53

Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer (2006) 3.38

Tooth loss is associated with increased risk of total death and death from upper gastrointestinal cancer, heart disease, and stroke in a Chinese population-based cohort. Int J Epidemiol (2005) 2.87

Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol (2010) 2.61

Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol (2004) 2.16

Prospective study of serum 25-hydroxyvitamin D concentration and mortality in a Chinese population. Am J Epidemiol (2012) 2.08

Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol (2011) 1.89

A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer (2011) 1.88

Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method. J Natl Cancer Inst (2012) 1.86

A pilot study of low-cost, high-resolution microendoscopy as a tool for identifying women with cervical precancer. Cancer Prev Res (Phila) (2012) 1.84

Estimation of cancer incidence and mortality attributable to smoking in China. Cancer Causes Control (2010) 1.68

Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst (2003) 1.68

Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr (2004) 1.65

EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer (2012) 1.63

Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst (2005) 1.63

Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine (2009) 1.39

A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine (2008) 1.38

Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev (2006) 1.34

Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer (2012) 1.32

Attributable causes of esophageal cancer incidence and mortality in China. PLoS One (2012) 1.31

Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. Hum Mol Genet (2012) 1.28

Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. Vaccine (2008) 1.26

Review of the cervical cancer disease burden in mainland China. Asian Pac J Cancer Prev (2011) 1.25

A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in China. Cancer Epidemiol (2012) 1.24

The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine (2011) 1.21

Inappropriate gold standard bias in cervical cancer screening studies. Int J Cancer (2007) 1.21

Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev (2003) 1.20

Inflation of sensitivity of cervical cancer screening tests secondary to correlated error in colposcopy. J Low Genit Tract Dis (2006) 1.18

Attributable causes of liver cancer mortality and incidence in china. Asian Pac J Cancer Prev (2013) 1.17

Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer (2011) 1.16

Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia. Cancer Epidemiol Biomarkers Prev (2007) 1.16

Cytologic detection of esophageal squamous cell carcinoma and its precursor lesions using balloon samplers and liquid-based cytology in asymptomatic adults in Llinxian, China. Acta Cytol (2008) 1.16

Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Cancer Causes Control (2009) 1.14

Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am J Epidemiol (2007) 1.13

Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies. Vaccine (2011) 1.12

Introduction of human papillomavirus DNA screening in the world: 15 years of experience. Vaccine (2012) 1.12

Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int J Cancer (2006) 1.12

The predicted impact of vaccination on human papillomavirus infections in Australia. Int J Cancer (2008) 1.11

Breast cancer stage at diagnosis and area-based socioeconomic status: a multicenter 10-year retrospective clinical epidemiological study in China. BMC Cancer (2012) 1.11

An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China. Cancer Prev Res (Phila) (2013) 1.10

Hepatitis C virus infection, Linxian, China. Emerg Infect Dis (2005) 1.10

Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Am J Epidemiol (2009) 1.08

Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population. Carcinogenesis (2013) 1.08

Regardless of skill, performing more biopsies increases the sensitivity of colposcopy. J Low Genit Tract Dis (2011) 1.07

Serum pepsinogens and risk of esophageal squamous dysplasia. Int J Cancer (2009) 1.07

No association between HPV infection and the neoplastic progression of esophageal squamous cell carcinoma: result from a cross-sectional study in a high-risk region of China. Int J Cancer (2006) 1.07

No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer (2010) 1.06

Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2004) 1.06

Polymorphisms in interleukin -2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk chinese population. Cancer Epidemiol Biomarkers Prev (2004) 1.06

The pathologic characteristics of breast cancer in China and its shift during 1999-2008: a national-wide multicenter cross-sectional image over 10 years. Int J Cancer (2012) 1.05

Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study. PLoS Med (2012) 1.05

Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer. Cancer Lett (2004) 1.05

Recommendations for cervical cancer prevention in Asia Pacific. Vaccine (2008) 1.04

Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection. Int J Cancer (2010) 1.04

Prospective study of serum retinol, beta-carotene, beta-cryptoxanthin, and lutein/zeaxanthin and esophageal and gastric cancers in China. Cancer Causes Control (2003) 1.03

Comprehensive control of human papillomavirus infections and related diseases. Vaccine (2013) 1.02

Semiquantitation of polycyclic aromatic hydrocarbon-DNA adducts in human esophagus by immunohistochemistry and the automated cellular imaging system. Cancer Epidemiol Biomarkers Prev (2002) 1.01

Epidemiological features of Human Papillomavirus (HPV) infection among women living in Mainland China. Asian Pac J Cancer Prev (2013) 1.00

Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC Public Health (2010) 1.00

Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study. Cancer Causes Control (2013) 1.00

Esophageal cancer mortality trends during the last 30 years in high risk areas in China: comparison of results from national death surveys conducted in the 1970's, 1990's and 2004-2005. Asian Pac J Cancer Prev (2011) 0.98

Serum concentrations of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) and risk of primary liver cancer. J Natl Cancer Inst (2006) 0.97

Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand. BMC Infect Dis (2013) 0.97

Prevalence of HPV Infection And Cervical Intraepithelial Neoplasia And Attitudes towards HPV Vaccination among Chinese Women Aged 18-25 in Jiangsu Province. Chin J Cancer Res (2011) 0.97

p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions. Oncol Rep (2006) 0.95

Lung cancer chemoprevention: a randomized, double-blind trial in Linxian, China. Cancer Epidemiol Biomarkers Prev (2006) 0.95

[Significance of screening by iodine staining of endoscopic examination in the area of high incidence of esophageal carcinoma]. Ai Zheng (2003) 0.94

Gene expression differences in normal esophageal mucosa associated with regression and progression of mild and moderate squamous dysplasia in a high-risk Chinese population. Cancer Res (2006) 0.94

Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study. BMJ (2012) 0.94

Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma. Cancer Prev Res (Phila) (2008) 0.93

Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study. Sex Transm Dis (2007) 0.93

Cost-benefit analysis of screening for esophageal and gastric cardiac cancer. Chin J Cancer (2011) 0.93

Cost-benefit analysis of esophageal cancer endoscopic screening in high-risk areas of China. World J Gastroenterol (2012) 0.92

A cross-sectional study on the acceptability of self-collection for HPV testing among women in rural China. Sex Transm Infect (2012) 0.91

Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China. Cancer Cytopathol (2011) 0.91

Risk factors for breast cancer among Chinese women: a 10-year nationwide multicenter cross-sectional study. J Epidemiol (2013) 0.91

Polycyclic aromatic hydrocarbon-DNA adducts determined by semiquantitative immunohistochemistry in human esophageal biopsies taken in 1985. Mutat Res (2004) 0.90

Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China. Am J Epidemiol (2009) 0.90

p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China. Int J Cancer (2013) 0.90

Cervical cancer screening in Middle Eastern and Asian migrants to Australia: a record linkage study. Cancer Epidemiol (2012) 0.90

A prospective study of polymorphisms of DNA repair genes XRCC1, XPD23 and APE/ref-1 and risk of stroke in Linxian, China. J Epidemiol Community Health (2007) 0.90

Estimation of cancer incidence and mortality attributable to overweight, obesity, and physical inactivity in China. Nutr Cancer (2011) 0.90

Combined screening of cervical cancer, breast cancer and reproductive tract infections in rural China. Asian Pac J Cancer Prev (2012) 0.89

Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens. J Virol Methods (2013) 0.89

Estimation of Cancer Burden Attributable to Infection in Asia. J Epidemiol (2015) 0.89

Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy. Chin J Cancer Res (2012) 0.89

A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China. Asian Pac J Cancer Prev (2012) 0.88

Prediagnostic plasma vitamin C and risk of gastric adenocarcinoma and esophageal squamous cell carcinoma in a Chinese population. Am J Clin Nutr (2013) 0.87

Modeling the Adenoma and Serrated pathway to Colorectal CAncer (ASCCA). Risk Anal (2013) 0.87

Cancer incidence and mortality in people aged less than 75 years: changes in Australia over the period 1987-2007. Cancer Epidemiol (2013) 0.87

Changing Trends in Vulvar Cancer Incidence and Mortality Rates in Australia Since 1982. Int J Gynecol Cancer (2015) 0.87